ADVFN Logo
Boards:
    Quotes:
      Boards
      News
      Market Data
      Markets
      Discover
      Subscribe Login/Register Profile Icon
      S&P 500
      5,303.27
      0.12%
      US Tech 100
      18,062.00
      -0.10%
      Dow Jones
      40,003.59
      0.34%
      Brent Oil
      83.76
      0.00%
      Bitcoin
      67,069.81
      -0.02%
      Registration Strip Icon for charts Register for streaming realtime charts, analysis tools, and prices.
      Get Started
      1. Home
      2. Investing
      3. Stocks
      4. USA
      5. NASDAQ
      6. Neurocrine Biosciences Inc (NBIX)

      7. Neurocrine Biosciences Inc (NBIX) News

      NBIX

      Neurocrine Biosciences (NBIX)

      Neurocrine Biosciences Inc
      		Date:
      Sort by:
       Showing the most relevant articles for your search:NASDAQ:NBIX
      DateTimeSourceHeadlineSymbolCompany
      3:00PMiHub NewswireFeaturedMusic Licensing, Inc. (OTC: SONG) Subsidiary Pro Music Rights Secures Final Judgment of $114,081.30 USD, Demonstrating Strength of Licensing Agreements
      05/17/20244:32PMEdgar (US Regulatory)Form 144 - Report of proposed sale of securitiesNASDAQ:NBIXNeurocrine Biosciences Inc
      05/17/20244:31PMEdgar (US Regulatory)Form 144 - Report of proposed sale of securitiesNASDAQ:NBIXNeurocrine Biosciences Inc
      05/17/20244:31PMEdgar (US Regulatory)Form 144 - Report of proposed sale of securitiesNASDAQ:NBIXNeurocrine Biosciences Inc
      05/16/20244:55PMEdgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of securitiesNASDAQ:NBIXNeurocrine Biosciences Inc
      05/16/20244:40PMEdgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of securitiesNASDAQ:NBIXNeurocrine Biosciences Inc
      05/14/20244:23PMEdgar (US Regulatory)Form 144 - Report of proposed sale of securitiesNASDAQ:NBIXNeurocrine Biosciences Inc
      05/14/20244:23PMEdgar (US Regulatory)Form 144 - Report of proposed sale of securitiesNASDAQ:NBIXNeurocrine Biosciences Inc
      05/14/20248:30AMPR Newswire (US)Neurocrine Biosciences Presented Baseline Data from the CAHtalyst™ Program in CAH and Study Data for Modified-Release Hydrocortisone in Primary Adrenal Insufficiency and CAH at ECE 2024NASDAQ:NBIXNeurocrine Biosciences Inc
      05/09/20249:45AMPR Newswire (US)Neurocrine Biosciences Presents CAHtalyst™ Adult Study Baseline Characteristics and Data on Impact of Supraphysiologic Glucocorticoid Therapy at AACE 2024NASDAQ:NBIXNeurocrine Biosciences Inc
      05/09/20248:30AMPR Newswire (US)Neurocrine Biosciences Announces Initiation of Phase 1 Clinical Study Evaluating Effects of NBI-1076986 in Healthy AdultsNASDAQ:NBIXNeurocrine Biosciences Inc
      05/08/20244:26PMEdgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of securitiesNASDAQ:NBIXNeurocrine Biosciences Inc
      05/08/20248:30AMPR Newswire (US)Neurocrine Biosciences Announces Initiation of Phase 1 Clinical Study Evaluating Effects of NBI-1117567 in Healthy AdultsNASDAQ:NBIXNeurocrine Biosciences Inc
      05/07/20244:15PMPR Newswire (US)Neurocrine Biosciences to Present at the BofA Securities 2024 Health Care ConferenceNASDAQ:NBIXNeurocrine Biosciences Inc
      05/07/20248:30AMPR Newswire (US)Neurocrine Biosciences to Present Phase 3 Baseline Characteristics Data from the CAHtalyst™ Program of Crinecerfont in CAH, and Data for Modified-Release Hydrocortisone in Primary Adrenal Insufficiency and CAH Studies at ECE 2024NASDAQ:NBIXNeurocrine Biosciences Inc
      05/06/20248:30AMPR Newswire (US)Neurocrine Biosciences Supports Tardive Dyskinesia Awareness Week by Advocating for Routine Screening and MonitoringNASDAQ:NBIXNeurocrine Biosciences Inc
      05/03/20241:15PMPR Newswire (US)Neurocrine Biosciences Presented CAHtalyst™ Pediatric Study Baseline Characteristics and CAHtalog™ Registry Data at PES 2024NASDAQ:NBIXNeurocrine Biosciences Inc
      05/01/20247:00AMPR Newswire (US)Neurocrine Biosciences Reports First Quarter 2024 Financial ResultsNASDAQ:NBIXNeurocrine Biosciences Inc
      04/30/20245:12PMPR Newswire (US)Neurocrine Biosciences Announces U.S. FDA Approval of INGREZZA® SPRINKLE (valbenazine) CapsulesNASDAQ:NBIXNeurocrine Biosciences Inc
      04/24/20248:30AMPR Newswire (US)Neurocrine Biosciences Launches WHAT THE C@H?! Educational Initiative to Support Congenital Adrenal Hyperplasia CommunityNASDAQ:NBIXNeurocrine Biosciences Inc
      04/23/20247:00AMPR Newswire (US)Neurocrine Biosciences Reports Positive Phase 2 Data for NBI-1065845 in Adults with Major Depressive DisorderNASDAQ:NBIXNeurocrine Biosciences Inc
      04/16/20244:01PMGlobeNewswire Inc.Sentia Medical Sciences and Neurocrine Biosciences Extend Research Collaboration to Discover Novel CRF PeptidesNASDAQ:NBIXNeurocrine Biosciences Inc
      04/10/20244:01PMPR Newswire (US)Neurocrine Biosciences Announces Conference Call and Webcast of First Quarter 2024 Financial ResultsNASDAQ:NBIXNeurocrine Biosciences Inc
      04/03/20248:30AMPR Newswire (US)Neurocrine Biosciences Announces First-Patient Dosed in Phase 2 Clinical Study Evaluating NBI-1070770 in Adults with Major Depressive DisorderNASDAQ:NBIXNeurocrine Biosciences Inc
      03/28/20248:30AMPR Newswire (US)Neurocrine Biosciences Announces Initiation of Phase 1 Clinical Study Evaluating Effects of NBI-1065890, a Second-Generation VMAT2 Inhibitor, in Healthy AdultsNASDAQ:NBIXNeurocrine Biosciences Inc
      03/11/20244:01PMPR Newswire (US)Neurocrine Biosciences to Participate at Virtual Investor Conferences in MarchNASDAQ:NBIXNeurocrine Biosciences Inc
      03/08/20244:22PMEdgar (US Regulatory)Form 144 - Report of proposed sale of securitiesNASDAQ:NBIXNeurocrine Biosciences Inc
      03/08/20244:22PMEdgar (US Regulatory)Form 144 - Report of proposed sale of securitiesNASDAQ:NBIXNeurocrine Biosciences Inc
      02/29/20247:02PMEdgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of securitiesNASDAQ:NBIXNeurocrine Biosciences Inc
      02/29/20246:55PMEdgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of securitiesNASDAQ:NBIXNeurocrine Biosciences Inc
       Showing the most relevant articles for your search:NASDAQ:NBIX